| Year |
Citation |
Score |
| 2023 |
Ourry V, Binette AP, St-Onge F, Strikwerda-Brown C, Chagnot A, Poirier J, Breitner J, Arenaza-Urquijo EM, Rabin JS, Buckley R, Gonneaud J, Marchant NL, Villeneuve S. How do modifiable risk factors affect Alzheimer's disease pathology or mitigate its effect on clinical symptom expression? Biological Psychiatry. PMID 37689129 DOI: 10.1016/j.biopsych.2023.09.003 |
0.362 |
|
| 2023 |
St-Onge F, Chapleau M, Breitner JC, Villeneuve S, Binette AP. Tau accumulation and its spatial progression across the Alzheimer's disease spectrum. Medrxiv : the Preprint Server For Health Sciences. PMID 37333413 DOI: 10.1101/2023.06.02.23290880 |
0.371 |
|
| 2022 |
Iturria-Medina Y, Adewale Q, Khan AF, Ducharme S, Rosa-Neto P, O'Donnell K, Petyuk VA, Gauthier S, De Jager PL, Breitner J, Bennett DA. Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity. Science Advances. 8: eabo6764. PMID 36399579 DOI: 10.1126/sciadv.abo6764 |
0.339 |
|
| 2021 |
Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, ... Breitner JC, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929 |
0.347 |
|
| 2020 |
Rabipour S, Rajagopal S, Yu E, Pasvanis S, Lafaille-Magnan ME, Breitner J, Rajah MN. APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset. Journal of Alzheimer's Disease : Jad. 76: 97-119. PMID 32474466 DOI: 10.3233/Jad-191292 |
0.434 |
|
| 2020 |
Breitner J, Meyer P. Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease Neurology. 94: 594-594. PMID 32229636 DOI: 10.1212/Wnl.0000000000009185 |
0.416 |
|
| 2020 |
McSweeney M, Pichet Binette A, Meyer PF, Gonneaud J, Bedetti C, Ozlen H, Labonté A, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF-tau in asymptomatic adults. Neurology. PMID 32015176 DOI: 10.1212/Wnl.0000000000008905 |
0.442 |
|
| 2019 |
Meyer PF, Savard M, Poirier J, Morgan D, Breitner J. Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31405825 DOI: 10.1016/J.Jalz.2019.05.007 |
0.45 |
|
| 2019 |
Miron J, Picard C, Labonté A, Auld D, Breitner J, Poirier J. Association of PPP2R1A with Alzheimer's disease and specific cognitive domains. Neurobiology of Aging. 81: 234-243. PMID 31349112 DOI: 10.1016/J.Neurobiolaging.2019.06.008 |
0.449 |
|
| 2019 |
Miron J, Picard C, Lafaille-Magnan MÉ, Savard M, Labonté A, Breitner J, Rosa-Neto P, Auld D, Poirier J. Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31175027 DOI: 10.1016/J.Jalz.2019.03.012 |
0.479 |
|
| 2019 |
Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P, Scheltens P, Poirier J, Saftig P, Bateman RJ, Breitner J, et al. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression. Nature Communications. 10: 2240. PMID 31110178 DOI: 10.1038/S41467-019-10152-W |
0.464 |
|
| 2019 |
Tam A, Dansereau C, Iturria-Medina Y, Urchs S, Orban P, Sharmarke H, Breitner J, Bellec P. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia. Gigascience. 8. PMID 31077314 DOI: 10.1093/Gigascience/Giz055 |
0.426 |
|
| 2019 |
Meyer PF, Tremblay-Mercier J, Leoutsakos J, Madjar C, Lafaille-Maignan MÉ, Savard M, Rosa-Neto P, Poirier J, Etienne P, Breitner J. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology. PMID 30952794 DOI: 10.1212/Wnl.0000000000007232 |
0.482 |
|
| 2019 |
Köbe T, Gonneaud J, Binette AP, Meyer P, McSweeney M, Rosa-Neto P, Breitner JC, Poirier J, Villeneuve S. P1-431: VASCULAR MEDICAL TREATMENTS INFLUENCE THE ASSOCIATION BETWEEN VASCULAR BURDEN AND AMYLOID PATHOLOGY IN ASYMPTOMATIC INDIVIDUALS AT RISK FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P430-P430. DOI: 10.1016/J.Jalz.2019.06.1036 |
0.423 |
|
| 2018 |
Meyer PF, Savard M, Poirier J, Labonté A, Rosa-Neto P, Weitz TM, Town T, Breitner J. Bi-Directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis. Journal of Alzheimer's Disease : Jad. PMID 29660934 DOI: 10.3233/Jad-170887 |
0.443 |
|
| 2017 |
Konishi K, Joober R, Poirier J, MacDonald K, Chakravarty M, Patel R, Breitner J, Bohbot VD. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29278888 DOI: 10.3233/Jad-170540 |
0.411 |
|
| 2017 |
Tardif CL, Devenyi GA, Amaral RSC, Pelleieux S, Poirier J, Rosa-Neto P, Breitner J, Chakravarty MM. Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease. Human Brain Mapping. PMID 29164798 DOI: 10.1002/Hbm.23897 |
0.47 |
|
| 2017 |
Krysinska K, Sachdev P, Breitner J, Kivipelto M, Kukull W, Brodaty H. Dementia registries around the globe and their applications: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28576507 DOI: 10.1016/J.Jalz.2017.04.005 |
0.337 |
|
| 2017 |
Verfaillie SC, Binette AP, Vachon-Presseau É, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JC, Villeneuve S. [P3-407]: SUBJECTIVE COGNITIVE DECLINE IS ASSOCIATED WITH ALTERED POSTERIOR CINGULATE CONNECTIVITY IN ELDERLY WITH A FAMILIAL HISTORY OF ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1120-P1121. DOI: 10.1016/J.Jalz.2017.06.1624 |
0.446 |
|
| 2016 |
Tam A, Dansereau C, Badhwar A, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P, Shmuel A, Breitner J, Bellec P. A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment. Data in Brief. 9: 1122-1129. PMID 27924300 DOI: 10.1016/J.Dib.2016.11.036 |
0.306 |
|
| 2016 |
Cavanagh C, Tse YC, Nguyen HB, Krantic S, Breitner JC, Quirion R, Wong TP. Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model. Neurobiology of Aging. 47: 41-49. PMID 27552480 DOI: 10.1016/J.Neurobiolaging.2016.07.009 |
0.308 |
|
| 2016 |
Margolin RA, Schneider LS, Cutter GR, Breitner JC, Doody RS, Landreth G, Chain D. P3-012: Advancing Therapeutics for Neuroinflammation in Alzheimer's Disease: Clinical Development Considerations Alzheimer's & Dementia. 12: P822-P822. DOI: 10.1016/J.Jalz.2016.06.1669 |
0.408 |
|
| 2015 |
Tam A, Dansereau C, Badhwar A, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P, Shmuel A, Wang S, Breitner J, Bellec P. Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies. Frontiers in Aging Neuroscience. 7: 242. PMID 26733866 DOI: 10.3389/Fnagi.2015.00242 |
0.412 |
|
| 2015 |
Orban P, Madjar C, Savard M, Dansereau C, Tam A, Das S, Evans AC, Rosa-Neto P, Breitner JC, Bellec P. Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease. Scientific Data. 2: 150043. PMID 26504522 DOI: 10.1038/Sdata.2015.43 |
0.457 |
|
| 2015 |
Chuang YF, An Y, Bilgel M, Wong DF, Troncoso JC, O'Brien RJ, Breitner JC, Ferruci L, Resnick SM, Thambisetty M. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Molecular Psychiatry. PMID 26324099 DOI: 10.1016/J.Jalz.2015.08.015 |
0.502 |
|
| 2015 |
Breitner JC. Comment: Yet another "disconnect" between amyloid and Alzheimer disease? Neurology. 85: 698. PMID 26208958 DOI: 10.1212/Wnl.0000000000001871 |
0.461 |
|
| 2015 |
Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke CG, Brockschnieder D, Dyrks T, Althoff V, Fraser PE, Hazrati LN, George-Hyslop PS, Breitner JC, Peters O, Multhaup G. Alzheimer amyloid peptide aβ42 regulates gene expression of transcription and growth factors. Journal of Alzheimer's Disease : Jad. 44: 613-24. PMID 25318543 DOI: 10.3233/Jad-141902 |
0.337 |
|
| 2015 |
Breitner JC. Observations on DSM-5 Mild Neurocognitive Disorder vs. its predecessor, Mild Cognitive Impairment. Acta Psychiatrica Scandinavica. 131: 15-7. PMID 24909394 DOI: 10.1111/Acps.12300 |
0.323 |
|
| 2015 |
Tremblay-Mercier J, Lafaille-Magnan M, Savard M, Pascoal TA, Labonté A, Fontaine D, Rosa-Neto P, Poirier J, Breitner J. Cerebrospinal fluid ad biomarkers predict poorer cognitive performance in a cognitively intact cohort at risk of Alzheimer’s dementia: The prevent-ad program Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1739 |
0.468 |
|
| 2014 |
Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P. Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging. Journal of Neuroinflammation. 11: 120. PMID 25005532 DOI: 10.1186/1742-2094-11-120 |
0.46 |
|
| 2014 |
Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner J, Dea D. Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease. Neurobiology of Aging. 35: S3-10. PMID 24973118 DOI: 10.1016/J.Neurobiolaging.2014.03.037 |
0.443 |
|
| 2014 |
Chuang YF, Breitner JC, Chiu YL, Khachaturian A, Hayden K, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP. Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study. Neurobiology of Aging. 35: 2429-35. PMID 24910391 DOI: 10.1016/J.Neurobiolaging.2014.05.002 |
0.452 |
|
| 2014 |
Breitner JC. Mild cognitive impairment and progression to dementia: new findings. Neurology. 82: e34-5. PMID 24470608 DOI: 10.1212/Wnl.0000000000000158 |
0.424 |
|
| 2014 |
Breitner JC. What should we do if we were wrong and Alzheimer was right? International Psychogeriatrics / Ipa. 26: 3-6. PMID 24135193 DOI: 10.1017/S1041610213001749 |
0.471 |
|
| 2014 |
Peterson D, Munger C, Crowley J, Corcoran C, Cruchaga C, Goate AM, Norton MC, Green RC, Munger RG, Breitner JC, Welsh-Bohmer KA, Lyketsos C, Tschanz J, Kauwe JS. Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 366-71. PMID 23727081 DOI: 10.1016/J.Jalz.2013.02.010 |
0.464 |
|
| 2014 |
Steinberg M, Hess K, Corcoran C, Mielke MM, Norton M, Breitner J, Green R, Leoutsakos J, Welsh-Bohmer K, Lyketsos C, Tschanz J. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. International Journal of Geriatric Psychiatry. 29: 153-9. PMID 23681754 DOI: 10.1002/Gps.3980 |
0.437 |
|
| 2014 |
Luck T, Riedel-Heller SG, Luppa M, Wiese B, Bachmann C, Jessen F, Bickel H, Weyerer S, Pentzek M, König HH, Prokein J, Eisele M, Wagner M, Mösch E, Werle J, ... ... Breitner JC, et al. A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study. Acta Psychiatrica Scandinavica. 129: 63-72. PMID 23521526 DOI: 10.1111/Acps.12129 |
0.416 |
|
| 2014 |
Breitner J. Anti-inflammatory treatments and Alzheimer's disease: a ‘double-edged sword’? Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.041 |
0.364 |
|
| 2014 |
Tam A, Orban P, Dansereau C, Belleville S, Benoit S, Dagher A, Joubert S, Monchi O, Peters F, Rosa-Neto P, Rouleau I, Shmuel A, Breitner JC, Bellec P. P4-118: CONNECTOME-WIDE ANALYSIS OF DIFFERENCES BETWEEN NORMAL AGING, MILD COGNITIVE IMPAIRMENT, AND DEMENTIA OF THE ALZHEIMER'S TYPE USING RESTING-STATE FMRI CONNECTIVITY Alzheimer's & Dementia. 10: P827-P828. DOI: 10.1016/J.Jalz.2014.05.1634 |
0.447 |
|
| 2014 |
Belleville S, LeBlanc AC, Duchesne S, Gaudreau P, Gauthier S, Hudon C, Kergoat M, Mechawar N, Gilbert A, Bocti C, Breitner JC, Calon F, Chertkow H, Doyon J, Fuhrer R, et al. P4-091: CIMA-Q: QUEBEC's CONSORTIUM TO IDENTIFY PRODROMAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P817-P818. DOI: 10.1016/J.Jalz.2014.05.1606 |
0.381 |
|
| 2014 |
Tremblay-Mercier J, Madjar C, Etienne P, Poirier J, Breitner JC. P4-070: A PROGRAM OF PRE-SYMPTOMATIC EVALUATION OF EXPERIMENTAL OR NOVEL TREATMENTS FOR ALZHEIMER'S DISEASE (PREVENT-AD): DESIGN, METHODS, AND PERSPECTIVES Alzheimer's & Dementia. 10: P808-P808. DOI: 10.1016/J.Jalz.2014.05.1585 |
0.419 |
|
| 2014 |
Hayden KM, Plassman BL, Potter GG, Norton MC, Tschanz JT, Darcey DJ, Zandi PP, Breitner JC, Welsh-Bohmer KA. O4-08-02: THE ASSOCIATION BETWEEN LIFETIME OCCUPATIONAL EXPOSURE TO PESTICIDES AND COGNITIVE DECLINE IN THE ELDERLY Alzheimer's & Dementia. 10: P266-P267. DOI: 10.1016/J.Jalz.2014.04.428 |
0.31 |
|
| 2013 |
Reckess GZ, Brandt J, Luis CA, Zandi P, Martin B, Breitner JC. Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial. Journal of Alzheimer's Disease : Jad. 36: 433-43. PMID 23645097 DOI: 10.3233/Jad-130113 |
0.399 |
|
| 2013 |
Peters ME, Rosenberg PB, Steinberg M, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner J, Tschanz JT, Lyketsos CG. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 1116-24. PMID 23567370 DOI: 10.1016/J.Jagp.2013.01.049 |
0.471 |
|
| 2013 |
Lafaille-Magnan M, Breitner J, Etienne P, Poirier J, Fontaine D, Rosa-Neto P, Rajah N. P1-160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease Alzheimer's & Dementia. 9: P208-P208. DOI: 10.1016/J.Jalz.2013.05.383 |
0.425 |
|
| 2013 |
Shao H, Breitner JC, Whitmer RA. Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study: Comment | Das kognitive "window of opportunity" der Hormontherapie Journal Fur Gynakologische Endokrinologie. 23: 41. |
0.301 |
|
| 2012 |
Shao H, Breitner JC, Whitmer RA, Wang J, Hayden K, Wengreen H, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology. 79: 1846-52. PMID 23100399 DOI: 10.1212/Wnl.0B013E318271F823 |
0.348 |
|
| 2012 |
Peters ME, Rosenberg PB, Steinberg M, Tschanz JT, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner JC, Lyketsos CG. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 416-24. PMID 22522960 DOI: 10.1097/Jgp.0B013E318211057D |
0.366 |
|
| 2012 |
Rosenberg PB, Mielke MM, Han D, Leoutsakos JS, Lyketsos CG, Rabins PV, Zandi PP, Breitner JC, Norton MC, Welsh-Bohmer KA, Zuckerman IH, Rattinger GB, Green RC, Corcoran C, Tschanz JT. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 1248-57. PMID 22374884 DOI: 10.1002/Gps.3769 |
0.403 |
|
| 2012 |
Norton MC, Dew J, Smith H, Fauth E, Piercy KW, Breitner JC, Tschanz J, Wengreen H, Welsh-Bohmer K. Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache County study. Journal of the American Geriatrics Society. 60: 405-12. PMID 22316091 DOI: 10.1111/J.1532-5415.2011.03860.X |
0.373 |
|
| 2012 |
Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG. Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. International Journal of Geriatric Psychiatry. 27: 364-74. PMID 21560159 DOI: 10.1002/Gps.2723 |
0.407 |
|
| 2012 |
Peterson A, Breitner J, Kaye J, Bowman G, Baker L, Clemons A, Montine T, Quinn J. Plasma Vitamin D, Cognitive Function, and Cerebrospinal Fluid Biomarkers in Subjects at Risk of Alzheimer's Disease (P02.064) Neurology. 78: P02.064-P02.064. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.064 |
0.399 |
|
| 2012 |
Luck T, Warren L, Welsh-Bohmer K, Riedel-Heller S, Maier W, Breitner J. P4-265: Disordered ‘instrumental’ abilities and impaired IADL as potent predictors of imminent dementia in persons with cognitive impairment Alzheimer's & Dementia. 8: S751-S752. DOI: 10.1016/J.Jalz.2013.08.046 |
0.382 |
|
| 2012 |
Luck T, Luppa M, Wiese B, Breitner J, Scherer M, Maier W, Riedel-Heller S. Mild cognitive impairment: Determinant patterns of short and long time to incident dementia Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.407 |
0.384 |
|
| 2012 |
Gilbert M, Hess K, Corcoran C, Snyder C, Norton M, Rao V, Welsh-Bohmer K, Breitner J, Lyketsos C, Tschanz J. Does the length of time between traumatic brain injury and the onset of Alzheimer's disease affect the rate of cognitive and functional progression?: The Cache County Dementia Progression Study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1357 |
0.439 |
|
| 2011 |
Norton MC, Smith KR, Østbye T, Tschanz JT, Schwartz S, Corcoran C, Breitner JC, Steffens DC, Skoog I, Rabins PV, Welsh-Bohmer KA. Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 814-24. PMID 21873837 DOI: 10.1097/Jgp.0B013E3182011B38 |
0.348 |
|
| 2011 |
Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, McCormick W, Bowen JD, Teri L, McCurry SM, Larson EB. Atrial fibrillation and risk of dementia: a prospective cohort study. Journal of the American Geriatrics Society. 59: 1369-75. PMID 21806558 DOI: 10.1111/J.1532-5415.2011.03508.X |
0.435 |
|
| 2011 |
Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN, et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 402-11. PMID 21784351 DOI: 10.1016/J.Jalz.2010.12.014 |
0.405 |
|
| 2011 |
Breitner JC. Further evidence for vascular mediation of Alzheimer's dementia pathogenesis? Biological Psychiatry. 70: 113-4. PMID 21708304 DOI: 10.1016/J.Biopsych.2011.05.026 |
0.454 |
|
| 2011 |
Tschanz JT, Corcoran CD, Schwartz S, Treiber K, Green RC, Norton MC, Mielke MM, Piercy K, Steinberg M, Rabins PV, Leoutsakos JM, Welsh-Bohmer KA, Breitner JC, Lyketsos CG. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 532-42. PMID 21606896 DOI: 10.1097/Jgp.0B013E3181Faec23 |
0.488 |
|
| 2011 |
Treiber KA, Carlson MC, Corcoran C, Norton MC, Breitner JC, Piercy KW, Deberard MS, Stein D, Foley B, Welsh-Bohmer KA, Frye A, Lyketsos CG, Tschanz JT. Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 66: 416-25. PMID 21441386 DOI: 10.1093/Geronb/Gbr023 |
0.47 |
|
| 2011 |
Gray SL, Walker R, Dublin S, Haneuse S, Crane PK, Breitner JC, Bowen J, McCormick W, Larson EB. Histamine-2 receptor antagonist use and incident dementia in an older cohort. Journal of the American Geriatrics Society. 59: 251-7. PMID 21314645 DOI: 10.1111/J.1532-5415.2010.03275.X |
0.451 |
|
| 2011 |
Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 15-34. PMID 21255741 DOI: 10.1016/J.Jalz.2010.11.005 |
0.514 |
|
| 2011 |
Breitner JC. Apolipoprotein e, Alzheimer's disease, and amyloid: do we have the cart before the horse? Journal of Alzheimer's Disease : Jad. 23: 171-2. PMID 21228459 DOI: 10.3233/Jad-2010-101351 |
0.417 |
|
| 2011 |
Kauwe J, Cawthon R, Kerber R, Tschanz J, Ward D, Norton M, Zandi P, Welsh-Bohmer K, Breitner J, Munger R. P1-283: Mitochondrial DNA haplogroup, AD incidence, and cognitive function: The Cache County study on memory, health, and aging Alzheimer's & Dementia. 7: S201-S201. DOI: 10.1016/J.Jalz.2011.05.564 |
0.363 |
|
| 2011 |
Peterson D, Kauwe J, Crowley J, Corcoran C, Cruchaga C, Goate A, Norton M, Green R, Munger R, Breitner J, Welsh-Bohmer K, Lyketsos K, Tschanz J. Support for Genetic Association Between Variants in PPP3R1 and MAPT and Rate of Progression of Alzheimer’s Disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.533 |
0.396 |
|
| 2011 |
Zandi P, Norton M, Tschanz J, Welsh-Bohmer K, Breitner J, Hayden K, Munger R, Whitmer R, Shao H, Szekely C, Wang J. O1-02-07: Timing and type of hormone replacement therapy and the risk of Alzheimer's disease: New findings from the cache county study Alzheimer's & Dementia. 7: S97-S97. DOI: 10.1016/J.Jalz.2011.05.237 |
0.363 |
|
| 2011 |
Tripodis Y, Mielke M, Sherva R, Corcoran C, Tschanz J, Welsh-Bohmer K, Breitner J, Lyketsos C, Green R. Gender modifying-effect between APOE and cognitive decline in Alzheimer's disease: The Cache County dementia progression study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1707 |
0.513 |
|
| 2011 |
Buckley T, Corcoran C, Schwartz S, Breitner J, Zandi P, Norton M, Deberard MS, Wengreen H, Foley B, Welsh-Bohmer K, Lyketsos C, Tschanz J. P2-169: NSAID use does not affect dementia progression or survival in Alzheimer's disease. The Cache County Dementia Progression Study. Alzheimer's & Dementia. 7: S367-S367. DOI: 10.1016/J.Jalz.2011.05.1056 |
0.479 |
|
| 2011 |
Tschanz J, Hatch D, Croasdell S, Wanzek J, Kauwe J, Corcoran C, Norton M, Green R, Munger R, Hayden K, Breitner J, Welsh-Bohmer K, Lyketsos C. Family history of non-Alzheimer's Demeutia memory problems predicts rate of cognitive decline in APOE E4 non-carriers in Alzheimer's disease: The Cache County Dementia Progression Study. Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1054 |
0.47 |
|
| 2011 |
Lee H, Norton M, Corcoran C, Tschanz J, Ostbye T, Smith K, Breitner J, Welsh-Bohmer K. P2-152: Late-life widowhood is associated with faster cognitive decline: The Cache County Study. Alzheimer's & Dementia. 7: S360-S360. DOI: 10.1016/J.Jalz.2011.05.1038 |
0.339 |
|
| 2011 |
Norton M, Dew J, Smith H, Fauth E, Piercy K, Breitner J, Tschanz J, Wengreen H, Welsh-Bohmer K. P2-151: Lifestyle behavior typologies predict incident dementia: The Cache County Study. Alzheimer's & Dementia. 7: S359-S360. DOI: 10.1016/J.Jalz.2011.05.1037 |
0.335 |
|
| 2010 |
Sonnen JA, Larson EB, Walker RL, Haneuse S, Crane PK, Gray SL, Breitner JC, Montine TJ. Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology. 75: 1203-10. PMID 20811000 DOI: 10.1212/Wnl.0B013E3181F52Db1 |
0.459 |
|
| 2010 |
Norton MC, Smith KR, Østbye T, Tschanz JT, Corcoran C, Schwartz S, Piercy KW, Rabins PV, Steffens DC, Skoog I, Breitner JC, Welsh-Bohmer KA. Greater risk of dementia when spouse has dementia? The Cache County study. Journal of the American Geriatrics Society. 58: 895-900. PMID 20722820 DOI: 10.1111/J.1532-5415.2010.02806.X |
0.436 |
|
| 2010 |
Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JC, Larson EB. Age-varying association between statin use and incident Alzheimer's disease. Journal of the American Geriatrics Society. 58: 1311-7. PMID 20533968 DOI: 10.1111/J.1532-5415.2010.02906.X |
0.467 |
|
| 2010 |
Hayden KM, Norton MC, Darcey D, Ostbye T, Zandi PP, Breitner JC, Welsh-Bohmer KA. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology. 74: 1524-30. PMID 20458069 DOI: 10.1212/Wnl.0B013E3181Dd4423 |
0.477 |
|
| 2010 |
Chuang YF, Hayden KM, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA, Zandi PP. Association between APOE epsilon4 allele and vascular dementia: The Cache County study. Dementia and Geriatric Cognitive Disorders. 29: 248-53. PMID 20375505 DOI: 10.1159/000285166 |
0.429 |
|
| 2010 |
Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee V, Roses A, Sager MA, Shankle WR, Snyder PJ, Petersen RC, Schellenberg G, Trojanowski J, Aisen P, Albert MS, Breitner JC, et al. Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 89-97. PMID 20298968 DOI: 10.1016/J.Jalz.2010.01.008 |
0.471 |
|
| 2010 |
Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ. Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 19: 301-9. PMID 20061646 DOI: 10.3233/Jad-2010-1236 |
0.435 |
|
| 2009 |
Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Archives of Neurology. 66: 1378-83. PMID 19901170 DOI: 10.1001/Archneurol.2009.237 |
0.454 |
|
| 2009 |
Norton MC, Piercy KW, Rabins PV, Green RC, Breitner JC, Ostbye T, Corcoran C, Welsh-Bohmer KA, Lyketsos CG, Tschanz JT. Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 64: 560-8. PMID 19564210 DOI: 10.1093/Geronb/Gbp052 |
0.491 |
|
| 2009 |
Breitner JC, Haneuse SJ, Walker R, Dublin S, Crane PK, Gray SL, Larson EB. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology. 72: 1899-905. PMID 19386997 DOI: 10.1212/Wnl.0B013E3181A18691 |
0.467 |
|
| 2009 |
Wang CS, Burke JR, Steffens DC, Hulette CM, Breitner JC, Plassman BL. Twin pairs discordant for neuropathologically confirmed Lewy body dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 80: 562-5. PMID 19372291 DOI: 10.1136/Jnnp.2008.151654 |
0.47 |
|
| 2009 |
Meinert CL, McCaffrey LD, Breitner JC. Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 93-104. PMID 19328435 DOI: 10.1016/J.Jalz.2008.09.004 |
0.437 |
|
| 2009 |
Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Annals of Neurology. 65: 226-9. PMID 19259965 DOI: 10.1002/Ana.21508 |
0.32 |
|
| 2009 |
Haneuse S, Schildcrout J, Crane P, Sonnen J, Breitner J, Larson E. Adjustment for selection bias in observational studies with application to the analysis of autopsy data. Neuroepidemiology. 32: 229-39. PMID 19176974 DOI: 10.1159/000197389 |
0.421 |
|
| 2009 |
Breitner JC, Thielke SM, Haneuse SJ, Walker RL, Zandi PP, Larson EB. P2-080: Variable association between use of NSAIDs and risk of AD in different samples: Does the disparity in results reflect the different age distributions of the participants? Alzheimer's & Dementia. 5: P285-P285. DOI: 10.1016/J.Jalz.2009.04.390 |
0.369 |
|
| 2009 |
Tschanz JT, Corcoran CD, Green RC, Munger R, Mielke MM, Norton MC, Rabins PV, Welsh-Bohmer KA, Buckley T, Breitner JC, Lyketsos CG. P1-069: Interaction between C-Reactive protein level and APOE genotype in predicting rate of progression in Alzheimer's disease: The Cache County dementia progression study Alzheimer's & Dementia. 5: P192-P192. DOI: 10.1016/J.Jalz.2009.04.073 |
0.424 |
|
| 2008 |
Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 883-92. PMID 18978249 DOI: 10.1097/Jgp.0B013E318181276A |
0.434 |
|
| 2008 |
Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JC, Montine TJ. Biomarkers for cognitive impairment and dementia in elderly people. The Lancet. Neurology. 7: 704-14. PMID 18635019 DOI: 10.1016/S1474-4422(08)70162-5 |
0.445 |
|
| 2008 |
Meinert CL, Breitner JC. Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S7-S14. PMID 18632005 DOI: 10.1016/J.Jalz.2007.10.007 |
0.374 |
|
| 2008 |
Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Szekely CA, Wengreen H, Munger RG, Norton MC, Tschanz JT, Lyketsos CG, Breitner JC, Welsh-Bohmer K. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 223-7. PMID 18631971 DOI: 10.1016/J.Jalz.2008.01.004 |
0.414 |
|
| 2008 |
Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, ... ... Breitner JC, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/J.Jalz.2008.03.005 |
0.427 |
|
| 2008 |
Szekely CA, Green RC, Breitner JC, Østbye T, Beiser AS, Corrada MM, Dodge HH, Ganguli M, Kawas CH, Kuller LH, Psaty BM, Resnick SM, Wolf PA, Zonderman AB, Welsh-Bohmer KA, et al. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology. 70: 2291-8. PMID 18509093 DOI: 10.1212/01.Wnl.0000313933.17796.F6 |
0.441 |
|
| 2008 |
Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radical Biology & Medicine. 45: 219-30. PMID 18482592 DOI: 10.1016/J.Freeradbiomed.2008.04.022 |
0.439 |
|
| 2008 |
Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Archives of Neurology. 65: 896-905. PMID 18474729 DOI: 10.1001/Archneur.2008.65.7.Nct70006 |
0.437 |
|
| 2008 |
Hallam BJ, Brown WS, Ross C, Buckwalter JG, Bigler ED, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JC. Regional atrophy of the corpus callosum in dementia. Journal of the International Neuropsychological Society : Jins. 14: 414-23. PMID 18419840 DOI: 10.1017/S1355617708080533 |
0.406 |
|
| 2008 |
Treiber KA, Lyketsos CG, Corcoran C, Steinberg M, Norton M, Green RC, Rabins P, Stein DM, Welsh-Bohmer KA, Breitner JC, Tschanz JT. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. International Psychogeriatrics / Ipa. 20: 538-53. PMID 18289451 DOI: 10.1017/S1041610208006704 |
0.454 |
|
| 2008 |
Gray SL, Anderson ML, Crane PK, Breitner JC, McCormick W, Bowen JD, Teri L, Larson E. Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. Journal of the American Geriatrics Society. 56: 291-5. PMID 18047492 DOI: 10.1111/J.1532-5415.2007.01531.X |
0.455 |
|
| 2008 |
Szekely CA, Breitner JC, Fitzpatrick AL, Rea TD, Psaty BM, Kuller LH, Zandi PP. NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology. 70: 17-24. PMID 18003940 DOI: 10.1212/01.Wnl.0000284596.95156.48 |
0.494 |
|
| 2008 |
Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 70: 440-8. PMID 17942819 DOI: 10.1212/01.Wnl.0000265401.62434.36 |
0.335 |
|
| 2008 |
Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, Breitner JC, Steffens DC, Tschanz JT. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry. 23: 170-7. PMID 17607801 DOI: 10.1002/Gps.1858 |
0.349 |
|
| 2008 |
Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. O3-03-08: The association between family history of Alzheimer's disease, APOE status, and cognitive decline Alzheimer's & Dementia. 4: T164-T165. DOI: 10.1016/J.Jalz.2008.05.430 |
0.439 |
|
| 2008 |
Larson EB, Crane P, McCurry SM, Bowen JD, McCormick WC, Teri L, Montine TJ, Craft S, Sonnen JA, Cholerton BA, Breitner JC. P4-034: Seattle adult changes in thought (ACT) study: A population-based “living laboratory” to study dementia and aging Alzheimer's & Dementia. 4: T677-T678. DOI: 10.1016/J.Jalz.2008.05.2098 |
0.34 |
|
| 2007 |
Thal L, Kuller L, Bowman K, Breitner J, Evans D, Farrer L, Frank R, Khachaturian AS, Khachaturian ZS, Kukull W, Nieto J, Petersen R, Sager M, Scherr P, Bain LJ. The Nevada Vital Aging Initiative: a private-public partnership to study early predictors of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 62-7. PMID 19595919 DOI: 10.1016/J.Jalz.2006.11.002 |
0.398 |
|
| 2007 |
Szekely CA, Breitner JC, Zandi PP. Prevention of Alzheimer's disease. International Review of Psychiatry (Abingdon, England). 19: 693-706. PMID 18092245 DOI: 10.1080/09540260701797944 |
0.447 |
|
| 2007 |
Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 69: 1850-8. PMID 17984453 DOI: 10.1212/01.Wnl.0000279520.59792.Fe |
0.484 |
|
| 2007 |
Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, Schantz A, Peskind ER, Raskind MA, Breitner JC, Montine TJ. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology. 69: 878-85. PMID 17724290 DOI: 10.1212/01.Wnl.0000277657.95487.1C |
0.487 |
|
| 2007 |
Li G, Rhew IC, Shofer JB, Kukull WA, Breitner JC, Peskind E, Bowen JD, McCormick W, Teri L, Crane PK, Larson EB. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. Journal of the American Geriatrics Society. 55: 1161-7. PMID 17661953 DOI: 10.1111/J.1532-5415.2007.01233.X |
0.365 |
|
| 2007 |
Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology. 69: 275-82. PMID 17636065 DOI: 10.1212/01.Wnl.0000265223.25679.2A |
0.431 |
|
| 2007 |
Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. 68: 1800-8. PMID 17460158 DOI: 10.1212/01.Wnl.0000260269.93245.D2 |
0.422 |
|
| 2007 |
Montine TJ, Li G, Sonnen J, Peskind E, Leverenz J, Haneuse S, Crane P, Breitner J, Larson E. O2-04-03: Structural bases of dementia in a typical U.S. urban and suburban population and their association with statin use Alzheimer's & Dementia. 3: S193-S193. DOI: 10.1016/J.Jalz.2007.04.298 |
0.319 |
|
| 2007 |
Li GG, Shofer J, Kukull WA, Peskind E, McCormick W, Bowen JD, Schellenberg GD, Crane P, Breitner JC, Larson EB. P-169: Association between statins and risk of AD is age dependent Alzheimer's & Dementia. 3: S152-S152. DOI: 10.1016/J.Jalz.2007.04.132 |
0.4 |
|
| 2007 |
Breitner JC, Gray SL, Anderson ML, Crane PK, McCormick W, Bowen J, Teri L, Larson EB. P-153: Antioxidant supplement use and risk of dementia and Alzheimer's disease in older adults Alzheimer's & Dementia. 3: S147-S147. DOI: 10.1016/J.Jalz.2007.04.116 |
0.437 |
|
| 2006 |
Welsh-Bohmer KA, Breitner JC, Hayden KM, Lyketsos C, Zandi PP, Tschanz JT, Norton MC, Munger R. Modifying dementia risk and trajectories of cognitive decline in aging: the Cache County Memory Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 257-60. PMID 19595895 DOI: 10.1016/J.Jalz.2006.04.011 |
0.486 |
|
| 2006 |
Plassman BL, Khachaturian AS, Townsend JJ, Ball MJ, Steffens DC, Leslie CE, Tschanz JT, Norton MC, Burke JR, Welsh-Bohmer KA, Hulette CM, Nixon RR, Tyrey M, Breitner JC. Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 2-11. PMID 19595851 DOI: 10.1016/J.Jalz.2005.11.001 |
0.456 |
|
| 2006 |
Plassman BL, Steffens DC, Burke JR, Welsh-Bohmer KA, Newman TN, Drosdick D, Helms MJ, Potter GG, Breitner JC. Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 9: 950-7. PMID 17254435 DOI: 10.1375/183242706779462381 |
0.444 |
|
| 2006 |
Steinberg M, Corcoran C, Tschanz JT, Huber C, Welsh-Bohmer K, Norton MC, Zandi P, Breitner JC, Steffens DC, Lyketsos CG. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry. 21: 824-30. PMID 16955439 DOI: 10.1002/Gps.1567 |
0.364 |
|
| 2006 |
Breitner JC. Dementia--epidemiological considerations, nomenclature, and a tacit consensus definition. Journal of Geriatric Psychiatry and Neurology. 19: 129-36. PMID 16880354 DOI: 10.1177/0891988706291081 |
0.435 |
|
| 2006 |
Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC, Hayden K, Norton MC, Zandi PP, Toone L, West NA, Breitner JC. Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology. 67: 229-34. PMID 16864813 DOI: 10.1212/01.Wnl.0000224748.48011.84 |
0.423 |
|
| 2006 |
Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Disease and Associated Disorders. 20: 93-100. PMID 16772744 DOI: 10.1097/01.Wad.0000213814.43047.86 |
0.416 |
|
| 2006 |
Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Archives of Neurology. 63: 686-92. PMID 16533956 DOI: 10.1001/Archneur.63.5.Noc60013 |
0.422 |
|
| 2006 |
Lopez OL, Becker JT, Jagust WJ, Fitzpatrick A, Carlson MC, DeKosky ST, Breitner J, Lyketsos CG, Jones B, Kawas C, Kuller LH. Neuropsychological characteristics of mild cognitive impairment subgroups. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 159-65. PMID 16103044 DOI: 10.1136/Jnnp.2004.045567 |
0.349 |
|
| 2006 |
McSweeney M, Binette AP, Meyer P, Gonneaud J, Bedetti C, Ozlen H, Daoust L, Labonte A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S. IC-P-209: EARLY INCREASE IN TAU-PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P-TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE-MIDDLE-AGED ADULTS Alzheimer's & Dementia. 14: P172-P173. DOI: 10.1016/J.Jalz.2018.06.2276 |
0.398 |
|
| 2006 |
Corcoran C, Tschanz J, Steinberg M, Schwartz S, Norton M, Welsh-Bohmer K, Breitner J, Lyketsos C. P2-127: Longitudinal course of neuropsychiatric symptoms in dementia. The cache county study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.965 |
0.353 |
|
| 2006 |
Tschanz JT, Cook L, Corcoran C, Norton M, Mielke M, Rosenberg P, Buckley T, Clay C, Welsh-Bohmer K, Breitner J, Lyketsos C. P2-126: Vascular factors and the rate of cognitive decline in dementia. The Cache County Study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.964 |
0.399 |
|
| 2006 |
Treiber K, Tschanz J, Corcoran C, Stein D, Steinberg M, Norton M, Welsh-Bohmer K, Breitner J, Lyketsos C. P1-258: Vascular factors are associated with increased risk of neuropsychiatric symptoms in Alzheimer’s disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.635 |
0.345 |
|
| 2006 |
Li G, Rhew IC, Shofer JB, Breitner JC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Teri L, Larson EB. P1-256: Age-dependent associations between blood pressure and risk of dementia: A community-based prospective cohort study Alzheimer's & Dementia. 2: S171-S171. DOI: 10.1016/J.Jalz.2006.05.633 |
0.342 |
|
| 2006 |
Craft S, Reger M, Baker LD, Watson GS, Fishel M, Cholerton B, Green P, Breitner JC, DeGroodt W, Frey WH. O3-05-05: Therapeutic effects of daily intranasal insulin administration in early Alzheimer's disease Alzheimer's & Dementia. 2: S63-S63. DOI: 10.1016/J.Jalz.2006.05.227 |
0.342 |
|
| 2006 |
Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Wengreen H, Munger R, Norton MC, Tschanz JT, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. P4-375: APOE-4 positive elderly taking anti-oxidant vitamins E and C in combination with NSAIDs develop less cognitive decline with aging: The Cache County study Alzheimer's & Dementia. 2: S628-S628. DOI: 10.1016/J.Jalz.2006.05.2116 |
0.331 |
|
| 2005 |
Hayden KM, Warren LH, Pieper CF, Østbye T, Tschanz JT, Norton MC, Breitner JC, Welsh-Bohmer KA. Identification of VaD and AD prodromes: the Cache County Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 19-29. PMID 19595812 DOI: 10.1016/J.Jalz.2005.06.002 |
0.505 |
|
| 2005 |
Montine TJ, Quinn JF, Montine KS, Kaye JA, Breitner JC. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 8: 359-67. PMID 16556967 DOI: 10.3233/Jad-2005-8405 |
0.353 |
|
| 2005 |
Tschanz JT, Treiber K, Norton MC, Welsh-Bohmer KA, Toone L, Zandi PP, Szekely CA, Lyketsos C, Breitner JC. A population study of Alzheimer's disease: findings from the Cache County Study on Memory, Health, and Aging. Care Management Journals : Journal of Case Management ; the Journal of Long Term Home Health Care. 6: 107-14. PMID 16544872 DOI: 10.1891/Cmaj.6.2.107 |
0.436 |
|
| 2005 |
Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology. 65: 1045-50. PMID 16217057 DOI: 10.1212/01.Wnl.0000178989.87072.11 |
0.481 |
|
| 2005 |
Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike CU, Corcoran C, Norton M, Zandi P, Breitner JC, Welsh-Bohmer K, Anthony J, Østbye T, Bigler E, Pieper C, et al. Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 13: 656-64. PMID 16085781 DOI: 10.1097/00019442-200508000-00004 |
0.421 |
|
| 2005 |
Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Archives of Neurology. 62: 1047-51. PMID 16009757 DOI: 10.1001/Archneur.62.7.1047 |
0.334 |
|
| 2005 |
Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, Pieper CF, Welsh-Bohmer KA, Breitner JC. Apolipoprotein E genotype and mortality: findings from the Cache County Study. Journal of the American Geriatrics Society. 53: 935-42. PMID 15935014 DOI: 10.1111/J.1532-5415.2005.53301.X |
0.395 |
|
| 2005 |
Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 64: 1548-52. PMID 15883315 DOI: 10.1212/01.Wnl.0000160115.55756.De |
0.498 |
|
| 2005 |
Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Kawas C, Carlson M. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 64: 1539-47. PMID 15883314 DOI: 10.1212/01.Wnl.0000159860.19413.C4 |
0.497 |
|
| 2005 |
Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Archives of General Psychiatry. 62: 217-24. PMID 15699299 DOI: 10.1001/Archpsyc.62.2.217 |
0.517 |
|
| 2005 |
Charoonruk G, Munger R, Wengreen H, Corcoran C, Hayden K, Bastian L, Tschanz J, Norton M, Breitner J, Welsh-Bohmer K. 362-S: Prospective Study of Diabetes, Gender, and Subsequent Risk of Alzheimer's Disease: The Cache County Study on Memory, Health, and Aging American Journal of Epidemiology. 161: S91-S91. DOI: 10.1093/Aje/161.Supplement_1.S91A |
0.37 |
|
| 2005 |
Fotuhi M, Zandi P, Hayden KM, Khachaturian AS, Wengreen H, Munger R, Norton MC, Tschanz JT, Breitner JC, Welsh-Bohmer KA. [O2-02-05]: Use of NSAIDs and antioxidant supplements in combination reduces the rate of cognitive decline. The Cache County study Alzheimer's & Dementia. 1: S97-S98. DOI: 10.1016/J.Jalz.2005.06.338 |
0.308 |
|
| 2005 |
Hayden KM, Zandi PP, Khachaturian AS, Norton MC, Tschanz JT, Pieper CF, Breitner JC, Welsh-Bohmer KA. [O2-02-04]: Statin use does not reduce cognitive decline in the elderly. The Cache County study Alzheimer's & Dementia. 1: S97-S97. DOI: 10.1016/J.Jalz.2005.06.337 |
0.328 |
|
| 2005 |
Hayden KM, Zandi PP, Wengreen HJ, Tschanz JT, Norton MC, Breitner JC, Welsh-Bohmer KA. [O2-01-07]: Does vitamin E use protect against dementia or increase the risk of mortality? Alzheimer's & Dementia. 1: S95-S96. DOI: 10.1016/J.Jalz.2005.06.332 |
0.312 |
|
| 2004 |
Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology. 23: 159-69. PMID 15279021 DOI: 10.1159/000078501 |
0.449 |
|
| 2004 |
Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry. 61: 518-24. PMID 15123497 DOI: 10.1001/Archpsyc.61.5.518 |
0.488 |
|
| 2004 |
Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM, Welsh-Bohmer KA, Calvert T, Norton MC, Zandi P, Breitner JC. Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology. 62: 1156-62. PMID 15079016 DOI: 10.1212/01.Wnl.0000118210.12660.C2 |
0.353 |
|
| 2004 |
Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JC. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Archives of Neurology. 61: 82-8. PMID 14732624 DOI: 10.1001/Archneur.61.1.82 |
0.431 |
|
| 2004 |
Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, Jones B, Lyketsos C, Dulberg C. Incidence and prevalence of dementia in the Cardiovascular Health Study. Journal of the American Geriatrics Society. 52: 195-204. PMID 14728627 DOI: 10.1111/J.1532-5415.2004.52058.X |
0.458 |
|
| 2004 |
Steinberg M, Tschanz JT, Corcoran C, Steffens DC, Norton MC, Lyketsos CG, Breitner JC. The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry. 19: 19-26. PMID 14716695 DOI: 10.1002/Gps.1025 |
0.31 |
|
| 2004 |
Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. P4-039 Clinical and MRI factors for vascular dementia in the cardiovascular health study cognition study Neurobiology of Aging. 25: S483-S484. DOI: 10.1016/S0197-4580(04)81597-5 |
0.385 |
|
| 2004 |
Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Kawas C, Carlson M. P4-038 Classification of vascular dementia in the cardiovascular health study cognition study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81596-3 |
0.387 |
|
| 2004 |
Norton MC, Steffens DC, Toone L, Tschanz JT, Hayden K, Corcoran C, Klein L, Zandi P, Breitner JC, Welsh-Bohmer KA. P3-108 Late-life depression, mild cognitive impairment, APOE and their interactive effects on conversion to dementia in a population-based study. The Cache County Study Neurobiology of Aging. 25: S385-S386. DOI: 10.1016/S0197-4580(04)81260-0 |
0.397 |
|
| 2004 |
Steinberg M, Corcoran C, Huber C, Welsh-Bohmer K, Norton M, Zandi P, Breitner J, Tschanz J, Lyketsos C. P2-333 A longitudinal model for neuropsychiatric symptoms in dementia: the Cache County Study Neurobiology of Aging. 25: S327-S328. DOI: 10.1016/S0197-4580(04)81076-5 |
0.346 |
|
| 2004 |
Tschanz J, Klein E, Treiber K, Corcoran C, Norton M, Toone L, Welsh-Bohmer K, Steinberg M, Munger R, Pieper C, Breitner J, Zandi P, Lyketsos C. P2-288 Neuropsychiatric symptoms in mild cognitive impairment and dementia: prevalence and relationship to cognitive and functional impairment. The Cache County Study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81033-9 |
0.389 |
|
| 2004 |
Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike C, Corcoran C, Norton M, Welsh-Bohmer K, Breitner J, Zandi P, Lyketsos CG. P2-247 A population based study of medical co-morbidity in early dementia and mild cognitive syndrome: association with functional and cognitive impairment Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80993-X |
0.38 |
|
| 2004 |
Klein E, Corcoran C, Tschanz J, Norton M, Welsh-Bohmer K, Breitner J, Zandi P, Lyketsos C. P1-051 Survival from memory symptom onset: a comparison of individuals with dementia and cognitive impairment. The cache county study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80365-8 |
0.378 |
|
| 2003 |
Sparks DL, Sabbagh MN, Breitner JC, Hunsaker JC. Is cholesterol a culprit in Alzheimer's disease? International Psychogeriatrics / Ipa. 15: 153-9. PMID 16191233 DOI: 10.1017/S1041610203009128 |
0.437 |
|
| 2003 |
Breitner JC, Costa PT. "At my wits' end": neuroticism and dementia. Neurology. 61: 1468-9. PMID 14663023 DOI: 10.1212/Wnl.61.11.1468 |
0.363 |
|
| 2003 |
Hayden KM, Khachaturian AS, Tschanz JT, Corcoran C, Nortond M, Breitner JC. Characteristics of a two-stage screen for incident dementia. Journal of Clinical Epidemiology. 56: 1038-45. PMID 14614994 DOI: 10.1016/S0895-4356(03)00247-6 |
0.342 |
|
| 2003 |
Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Archives of Neurology. 60: 1394-9. PMID 14568809 DOI: 10.1001/Archneur.60.10.1394 |
0.417 |
|
| 2003 |
Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Archives of Neurology. 60: 1385-9. PMID 14568808 DOI: 10.1001/Archneur.60.10.1385 |
0.39 |
|
| 2003 |
Breitner JC, Zandi PP. Effects of estrogen plus progestin on risk of dementia. Jama. 290: 1706-7; author reply. PMID 14519698 DOI: 10.1001/Jama.290.13.1706-B |
0.378 |
|
| 2003 |
Breitner JC. Alzheimer disease in Turkey too. Alzheimer Disease and Associated Disorders. 17: 137-8. PMID 14512825 DOI: 10.1097/00002093-200307000-00002 |
0.448 |
|
| 2003 |
Breitner JC. NSAIDs and Alzheimer's disease: how far to generalise from trials? The Lancet. Neurology. 2: 527. PMID 12941571 DOI: 10.1016/S1474-4422(03)00498-8 |
0.421 |
|
| 2003 |
Steinberg M, Sheppard JM, Tschanz JT, Norton MC, Steffens DC, Breitner JC, Lyketsos CG. The incidence of mental and behavioral disturbances in dementia: the cache county study. The Journal of Neuropsychiatry and Clinical Neurosciences. 15: 340-5. PMID 12928510 DOI: 10.1176/Jnp.15.3.340 |
0.318 |
|
| 2003 |
Steffens DC, Norton MC, Hart AD, Skoog I, Corcoran C, Breitner JC. Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study. Psychological Medicine. 33: 541-7. PMID 12701674 DOI: 10.1017/S0033291702007201 |
0.347 |
|
| 2003 |
Leroi I, Voulgari A, Breitner JC, Lyketsos CG. The epidemiology of psychosis in dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 83-91. PMID 12527543 DOI: 10.1097/00019442-200301000-00011 |
0.497 |
|
| 2002 |
Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. Jama. 288: 2123-9. PMID 12413371 DOI: 10.1001/JAMA.288.17.2123 |
0.365 |
|
| 2002 |
Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 59: 880-6. PMID 12297571 DOI: 10.1212/Wnl.59.6.880 |
0.348 |
|
| 2002 |
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, Dekosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study Journal of the American Medical Association. 288: 1475-1483. PMID 12243634 DOI: 10.1001/Jama.288.12.1475 |
0.44 |
|
| 2002 |
Bigler ED, Kerr B, Victoroff J, Tate DF, Breitner JC. White matter lesions, quantitative magnetic resonance imaging, and dementia. Alzheimer Disease and Associated Disorders. 16: 161-70. PMID 12218647 DOI: 10.1097/00002093-200207000-00006 |
0.33 |
|
| 2002 |
Zandi PP, Breitner JC, Anthony JC. Is pharmacological prevention of Alzheimer's a realistic goal? Expert Opinion On Pharmacotherapy. 3: 365-80. PMID 11934339 DOI: 10.1517/14656566.3.4.365 |
0.385 |
|
| 2002 |
Carlson MC, Tschanz JT, Norton MC, Welsh-Bohmer K, Martin BK, Breitner JC. H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine. Alzheimer Disease and Associated Disorders. 16: 24-30. PMID 11882746 DOI: 10.1097/00002093-200201000-00004 |
0.437 |
|
| 2002 |
Martin BK, Meinert CL, Breitner JC. Double placebo design in a prevention trial for Alzheimer's disease. Controlled Clinical Trials. 23: 93-9. PMID 11852171 DOI: 10.1016/S0197-2456(01)00189-1 |
0.318 |
|
| 2002 |
Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology. 58: 209-18. PMID 11805246 DOI: 10.1212/Wnl.58.2.209 |
0.411 |
|
| 2001 |
Breitner JC, Zandi PP. Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? The New England Journal of Medicine. 345: 1567-8. PMID 11794225 DOI: 10.1056/Nejm200111223452110 |
0.332 |
|
| 2001 |
Carlson MC, Zandi PP, Plassman BL, Tschanz JT, Welsh-Bohmer KA, Steffens DC, Bastian LA, Mehta KM, Breitner JC. Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study. Neurology. 57: 2210-6. PMID 11756599 DOI: 10.1212/Wnl.57.12.2210 |
0.371 |
|
| 2001 |
Zandi PP, Breitner JC. Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence. Neurobiology of Aging. 22: 811-7. PMID 11754987 DOI: 10.1016/S0197-4580(01)00297-4 |
0.447 |
|
| 2001 |
Lyketsos CG, Sheppard JM, Steinberg M, Tschanz JA, Norton MC, Steffens DC, Breitner JC. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. International Journal of Geriatric Psychiatry. 16: 1043-53. PMID 11746650 DOI: 10.1002/Gps.448 |
0.449 |
|
| 2001 |
Lyketsos CG, Breitner JC, Rabins PV. An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. International Journal of Geriatric Psychiatry. 16: 1037-42. PMID 11746649 DOI: 10.1002/Gps.440 |
0.405 |
|
| 2000 |
Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, Phillips C, Gau BA, Welsh-Bohmer KA, Burke JR, Guralnik JM, Breitner JC. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology. 55: 1158-66. PMID 11071494 DOI: 10.1212/Wnl.55.8.1158 |
0.413 |
|
| 2000 |
Breitner JC. Epidemiologic clues to the causes and routes to prevention of Alzheimer disease. Journal of Neural Transmission. Supplementum. 59: 251-4. PMID 10961436 |
0.323 |
|
| 2000 |
Anthony JC, Breitner JC, Zandi PP, Meyer MR, Jurasova I, Norton MC, Stone SV. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology. 54: 2066-71. PMID 10851364 DOI: 10.1212/Wnl.54.11.2066 |
0.34 |
|
| 2000 |
Khachaturian AS, Gallo JJ, Breitner JC. Performance characteristics of a two-stage dementia screen in a population sample. Journal of Clinical Epidemiology. 53: 531-40. PMID 10812327 DOI: 10.1016/S0895-4356(99)00196-1 |
0.366 |
|
| 2000 |
Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. The American Journal of Psychiatry. 157: 708-14. PMID 10784462 DOI: 10.1176/Appi.Ajp.157.5.708 |
0.409 |
|
| 2000 |
Tschanz JT, Welsh-Bohmer KA, Skoog I, West N, Norton MC, Wyse BW, Nickles R, Breitner JC. Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology. 54: 1290-6. PMID 10746600 DOI: 10.1212/Wnl.54.6.1290 |
0.378 |
|
| 2000 |
Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Newman TT, Breitner JC. APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives. Neurology. 54: 593-8. PMID 10680788 DOI: 10.1212/Wnl.54.3.593 |
0.44 |
|
| 2000 |
Heun R, Papassotiropoulos A, Jessen F, Maier W, Breitner J. P02.255 The relationship between alzheimer's disease, early onset and late-onset depression in the elderly assessed in a family study European Psychiatry. 15: 390s-390s. DOI: 10.1016/S0924-9338(00)94663-7 |
0.393 |
|
| 2000 |
Plassman BL, Steffens DC, Welsh-Bohmer KA, Helms MJ, Newman TN, Drosdick DL, Meyer JM, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of aging veteran twins Neurobiology of Aging. 21: 80. DOI: 10.1016/S0197-4580(00)82584-1 |
0.406 |
|
| 1999 |
Breitner JC. The end of Alzheimer's disease? International Journal of Geriatric Psychiatry. 14: 577-86. PMID 10440980 DOI: 10.1002/(Sici)1099-1166(199907)14:7<577::Aid-Gps32>3.0.Co;2-M |
0.44 |
|
| 1999 |
Breitner JC, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, Tschanz JT, Plassman BL, Meyer MR, Skoog I, Khachaturian A. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 53: 321-31. PMID 10430421 DOI: 10.1212/Wnl.53.2.321 |
0.482 |
|
| 1999 |
Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Newman TT, Breitner JC. APOLIPOPROTEIN-E GENOTYPE, CONCORDANCE, AND DISCORDANCE OF ALZHEIMER's DISEASE (AD) IN TWIN PAIRS AS PREDICTORS OF AD IN FIRST-DEGREE RELATIVES The American Journal of Geriatric Psychiatry. 7: 60-61. DOI: 10.1097/00019442-199911001-00172 |
0.473 |
|
| 1998 |
Breitner JC. Exposure classification: the bugbear of dementia epidemiology. Neurobiology of Aging. 19: 613-4; discussion 61. PMID 10192222 DOI: 10.1016/S0197-4580(98)00102-X |
0.338 |
|
| 1998 |
Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, Breitner JC. APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease. Nature Genetics. 19: 321-2. PMID 9697689 DOI: 10.1038/1206 |
0.405 |
|
| 1998 |
Breitner JC, Jarvik GP, Plassman BL, Saunders AM, Welsh KA. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years. Alzheimer Disease and Associated Disorders. 12: 40-4. PMID 9539409 DOI: 10.1097/00002093-199803000-00006 |
0.447 |
|
| 1998 |
Meyer JM, Breitner JC. Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. American Journal of Medical Genetics. 81: 92-7. PMID 9514594 DOI: 10.1002/(Sici)1096-8628(19980207)81:1<92::Aid-Ajmg16>3.0.Co;2-R |
0.46 |
|
| 1997 |
Plassman BL, Breitner JC. The genetics of dementia in late life. The Psychiatric Clinics of North America. 20: 59-76. PMID 9139296 DOI: 10.1016/S0193-953X(05)70393-2 |
0.486 |
|
| 1997 |
Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology. 48: 985-9. PMID 9109888 DOI: 10.1212/Wnl.48.4.985 |
0.373 |
|
| 1997 |
Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biological Psychiatry. 41: 851-6. PMID 9099411 DOI: 10.1016/S0006-3223(96)00247-8 |
0.41 |
|
| 1996 |
Breitner JC. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiology of Aging. 17: 789-94. PMID 8892353 DOI: 10.1016/0197-4580(96)00109-1 |
0.443 |
|
| 1996 |
Plassman BL, Breitner JC. Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions. Journal of the American Geriatrics Society. 44: 1242-50. PMID 8856006 DOI: 10.1111/J.1532-5415.1996.Tb01377.X |
0.431 |
|
| 1996 |
Plassman BL, Breitner JC. Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology. 47: 317-20. PMID 8756999 DOI: 10.1212/Wnl.47.2.317 |
0.479 |
|
| 1996 |
Breitner JC. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annual Review of Medicine. 47: 401-11. PMID 8712791 DOI: 10.1146/Annurev.Med.47.1.401 |
0.426 |
|
| 1996 |
Saunders AM, Hulette O, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, Alberts MJ, Strittmatter WJ, Breitner JC, Rosenberg C. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (London, England). 348: 90-3. PMID 8676723 DOI: 10.1016/S0140-6736(96)01251-2 |
0.425 |
|
| 1996 |
Breitner JC. APOE genotyping and Alzheimer's disease. Lancet. 347: 1184-5. PMID 8609780 DOI: 10.1016/S0140-6736(96)90642-X |
0.446 |
|
| 1996 |
Roses A, Saunders A, Hulette C, Welsh K, Crain B, Burke J, Alberts M, Strittmatter W, Breitner J, Earl N, Clark C, Heyman A, Gaskell P, Pericak-Vance M. 295 Predictive value of APOE genotyping in a consecutive series of autopsied sporadic probable Alzheimer disease patients Neurobiology of Aging. 17: S74. DOI: 10.1016/S0197-4580(96)80297-1 |
0.389 |
|
| 1995 |
Gallo JJ, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychological Medicine. 25: 1211-9. PMID 8637951 DOI: 10.1017/S0033291700033183 |
0.494 |
|
| 1995 |
Hocking LB, Breitner JC. Cumulative risk of Alzheimer-like dementia in relatives of autopsy-confirmed cases of Alzheimer's disease. Dementia (Basel, Switzerland). 6: 355-6. PMID 8563790 |
0.41 |
|
| 1995 |
Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiology of Aging. 16: 523-30. PMID 8544901 DOI: 10.1016/0197-4580(95)00049-K |
0.432 |
|
| 1995 |
Breitner JC, Welsh KA. Genes and recent developments in the epidemiology of Alzheimer's disease and related dementia. Epidemiologic Reviews. 17: 39-47. PMID 8521945 DOI: 10.1093/Oxfordjournals.Epirev.A036184 |
0.441 |
|
| 1995 |
Plassman BL, Helms MJ, Welsh KA, Saunders AM, Breitner JC. Smoking, Alzheimer's disease, and confounding with genes. Lancet. 345: 387. PMID 7772122 DOI: 10.1016/S0140-6736(95)90374-7 |
0.34 |
|
| 1995 |
Plassman BL, Welsh KA, Helms M, Brandt J, Page WF, Breitner JC. Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology. 45: 1446-50. PMID 7644038 DOI: 10.1212/Wnl.45.8.1446 |
0.339 |
|
| 1995 |
Breitner JC, Welsh KA, Gau BA, McDonald WM, Steffens DC, Saunders AM, Magruder KM, Helms MJ, Plassman BL, Folstein MF. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Archives of Neurology. 52: 763-71. PMID 7639628 DOI: 10.1001/Archneur.1995.00540320035011 |
0.448 |
|
| 1994 |
Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 44: 227-32. PMID 8309563 DOI: 10.1212/Wnl.44.2.227 |
0.424 |
|
| 1994 |
Breitner JC, Welsh KA, Robinette CD, Gau BA, Folstein MF, Brandt J. Alzheimer's disease in the NAS-NRC registry of aging twin veterans. II. Longitudinal findings in a pilot series. National Academy of Sciences. National Research Council Registry. Dementia (Basel, Switzerland). 5: 99-105. PMID 8038872 DOI: 10.1159/000106703 |
0.473 |
|
| 1994 |
Norton MC, Breitner JC, Welsh KA, Wyse BW. Characteristics of nonresponders in a community survey of the elderly. Journal of the American Geriatrics Society. 42: 1252-6. PMID 7983287 DOI: 10.1111/J.1532-5415.1994.Tb06506.X |
0.331 |
|
| 1994 |
Breitner JC. New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause. Neurobiology of Aging. 15: S175-7. PMID 7700447 DOI: 10.1016/0197-4580(94)90199-6 |
0.417 |
|
| 1993 |
Brandt J, Welsh KA, Breitner JC, Folstein MF, Helms M, Christian JC. Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs. Archives of Neurology. 50: 599-603. PMID 8503796 DOI: 10.1001/Archneur.1993.00540060039014 |
0.319 |
|
| 1993 |
Breitner JC, Gatz M, Bergem AL, Christian JC, Mortimer JA, McClearn GE, Heston LL, Welsh KA, Anthony JC, Folstein MF. Use of twin cohorts for research in Alzheimer's disease. Neurology. 43: 261-7. PMID 8437688 DOI: 10.1212/Wnl.43.2.261 |
0.454 |
|
| 1993 |
Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342: 710-1. PMID 8103823 DOI: 10.1016/0140-6736(93)91709-U |
0.463 |
|
| 1992 |
Murphy EA, Breitner JC. Threshold model in the genetics of age-dependent disease in twins: I. General principles as applied to Alzheimer disease. American Journal of Medical Genetics. 42: 842-50. PMID 1554025 DOI: 10.1002/Ajmg.1320420620 |
0.372 |
|
| 1991 |
Breitner JC, Murphy EA, Woodbury MA. Case-control studies of environmental influences in diseases with genetic determinants, with an application to Alzheimer's disease. American Journal of Epidemiology. 133: 246-56. PMID 2000842 DOI: 10.1093/Oxfordjournals.Aje.A116240 |
0.347 |
|
| 1991 |
Breitner JC. Clinical genetics and genetic counseling in Alzheimer disease. Annals of Internal Medicine. 115: 601-6. PMID 1892331 DOI: 10.7326/0003-4819-601 |
0.373 |
|
| 1990 |
Breitner JC, Husain MM, Figiel GS, Krishnan KR, Boyko OB. Cerebral white matter disease in late-onset paranoid psychosis. Biological Psychiatry. 28: 266-74. PMID 2378929 DOI: 10.1016/0006-3223(90)90582-M |
0.349 |
|
| 1990 |
Breitner JC. Life table methods and assessment of familial risk in Alzheimer's disease. Archives of General Psychiatry. 47: 395-6. PMID 2360948 DOI: 10.1001/Archpsyc.1990.01810160095017 |
0.488 |
|
| 1990 |
Breitner JC. Estimation of familial risk in Alzheimer's disease. Annals of Neurology. 27: 338-40. PMID 2327743 DOI: 10.1002/Ana.410270321 |
0.397 |
|
| 1990 |
Breitner JC, Murphy EA, Folstein MF, Magruder-Habib K. Twin studies of Alzheimer's disease: an approach to etiology and prevention. Neurobiology of Aging. 11: 641-8. PMID 2280807 DOI: 10.1016/0197-4580(90)90030-4 |
0.46 |
|
| 1989 |
Breitner JC, Magruder-Habib KM. Criteria for onset critically influence the estimation of familial risk in Alzheimer's disease. Genetic Epidemiology. 6: 663-9. PMID 2691325 DOI: 10.1002/Gepi.1370060603 |
0.508 |
|
| 1988 |
Breitner JC, Murphy EA, Silverman JM, Mohs RC, Davis KL. Age-dependent expression of familial risk in Alzheimer's disease. American Journal of Epidemiology. 128: 536-48. PMID 3414659 DOI: 10.1093/Oxfordjournals.Aje.A115001 |
0.458 |
|
| 1988 |
Breitner JC, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology. 38: 207-12. PMID 3340281 DOI: 10.1212/Wnl.38.2.207 |
0.442 |
|
| 1987 |
Mohs RC, Breitner JC, Silverman JM, Davis KL. Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. Archives of General Psychiatry. 44: 405-8. PMID 3579492 DOI: 10.1001/Archpsyc.1987.01800170019003 |
0.444 |
|
| 1987 |
Silverman J, Breitner J, Mohs R, Davis K. Reliability of the family history method in genetic studies of Alzheimer??s disease and related dementias Alzheimer Disease & Associated Disorders. 1: 200. DOI: 10.1097/00002093-198701030-00013 |
0.432 |
|
| 1986 |
Silverman JM, Breitner JC, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. The American Journal of Psychiatry. 143: 1279-82. PMID 3766791 DOI: 10.1176/Ajp.143.10.1279 |
0.392 |
|
| 1986 |
Breitner JC, Murphy EA, Folstein MF. Familial aggregation in Alzheimer dementia--II. Clinical genetic implications of age-dependent onset. Journal of Psychiatric Research. 20: 45-55. PMID 3712290 DOI: 10.1016/0022-3956(86)90022-1 |
0.408 |
|
| 1986 |
Breitner JC, Folstein MF, Murphy EA. Familial aggregation in Alzheimer dementia--I. A model for the age-dependent expression of an autosomal dominant gene. Journal of Psychiatric Research. 20: 31-43. PMID 3712289 DOI: 10.1016/0022-3956(86)90021-X |
0.416 |
|
| 1985 |
Breitner JC. Dementia of the Alzheimer type: methodological comments. Psychiatry Research. 16: 263-6. PMID 4089056 DOI: 10.1016/0165-1781(85)90115-5 |
0.45 |
|
| 1984 |
Breitner JC. Aphasia/apraxia and familial aggregation in Alzheimer's disease. Annals of Neurology. 15: 614-5. PMID 6742800 DOI: 10.1002/Ana.410150626 |
0.384 |
|
| 1984 |
Breitner JC, Folstein MF. Familial nature of Alzheimer's disease. The New England Journal of Medicine. 311: 192. PMID 6738605 DOI: 10.1056/Nejm198407193110316 |
0.401 |
|
| 1984 |
Breitner JC, Folstein MF. Familial Alzheimer Dementia: a prevalent disorder with specific clinical features. Psychological Medicine. 14: 63-80. PMID 6200894 DOI: 10.1017/S0033291700003081 |
0.439 |
|
| 1983 |
Chase GA, Folstein MF, Breitner JC, Beaty TH, Self SG. The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer's disease. American Journal of Epidemiology. 117: 590-7. PMID 6846316 DOI: 10.1093/Oxfordjournals.Aje.A113581 |
0.351 |
|
| Show low-probability matches. |